bpc 157 bones BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven Orthopedic Use of BPC-157 -

Xilouri, M

Unlike many short signaling peptides that rapidly degrade in biological systems, BPC-157 exhibits relatively high structural stability and resistance to proteolytic breakdown

Based on historical data, attachment loss improved by 2.0 mm 6 months after surgery alone, while improvement reached 3.4 mm following DPSC injection, with a standard deviation of 1.7 mm

Two recovery peptides, one synergistic effect Each peptide in the BPC Wolverine formulation plays a distinct role in healing and together they create a more complete recovery response than either alone

The majority of the published data is still preclinical, and there are still plenty of issues concerning the safety, pharmacology and effectiveness of the use of BPC-157 to be answered

Each batch is tested in-house by HPLC and mass spec, then re-tested by an outside ISO 17025 lab